Korean J Occup Environ Med.  1997 Jun;9(2):267-274.

Phototoxic Dermatitis by Coal Tar Containing Paint

Affiliations
  • 1Inha University, Medical College, Department of Preventive Medicine, Korea.
  • 2Ewha Womans University, Medical College, Department of Preventive Medicine, Korea.

Abstract

Many workers who used coal tar containing paints in shipyard industry have dermatitis, but the etiology is not known well. Our research is to fond out the etiology of the dermatitis and to provide proper management. Methods of this research are comprised of 3 steps. First, we diagnosed dermatitis by questionnaire and dermatologic examination and evaluated air level of coal tar pitch volatiles in workplace. Second, we confirmed coal tar phototoxicity by in vitro cell experiments. Third, we evaluated the effects of intervention. The results were as follows ; Questionnaire survey showed that the lesions of dermatitis were mainly on the sun exposed area and the symptoms were strongly associated with season, weather, and time. Air levels of coal tar pitch volatiles in workplace were higher than NIOSH standard (0.1 mg/m(3), cyclohexane solubles). Inhibitory effects of cellular proliferation by coal tar containing paints and UVA (365nm) exposure showed coal tar phototoxicity. Intervention was done by UV barrier cream(BPF 30) and 72.7% workers who applied UV barrier cream improved after 2 months later. Conclusively, the etiology of dermatitis of shipyard workers who used coal tar containing paint was coal tar phototoxicity, and this dermatitis would be protected by UV barrier cream.

Keyword

Coal tar; UVA; Phototoxicity; Dermatitis

MeSH Terms

Cell Proliferation
Coal Tar*
Coal*
Dermatitis
Dermatitis, Phototoxic*
National Institute for Occupational Safety and Health (U.S.)
Paint*
Questionnaires
Seasons
Solar System
Weather
Coal
Coal Tar
Full Text Links
  • KJOEM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr